Seqanswers Leaderboard Ad

Collapse

Announcement

Collapse
No announcement yet.
X
 
  • Filter
  • Time
  • Show
Clear All
new posts

  • Cuffdiff-confidence interval

    Hi, everybody, I have a problem about cuffdiff. I used cuffdiff to test differential expression. However, I checked the "genes.fpkm_tracking". All the FPKM estimate have q1_conf_lo=0, and q1_conf_hi a big number, which means the 95% confidence interval are very large. It seems not reasonable. I am not sure if the test statistic is calculated by this intervals. If it is, then the number of the deferentially expressed genes would be smaller.

    I also try to use cufflinks to estimate the expression level. and "genes.fpkm_tracking" produced by cufflinks have reasonable intervals. I remember cuffdiff used cufflinks quantification engine. So they should have similar result, right? Anyone have any ideas for this problems?

    Thanks a lot

  • #2
    did you get any answer?

    ib

    Comment


    • #3
      did you find a solution? I have the same problem...

      ib

      Comment


      • #4
        No, I did not get reply.
        However, I think the variance difference is just caused by numerical reasons. Since I do not have experimental replicate, using cufflinks to estimate the expression only consider the variance from the model, such as the variation resulting from the assignment a read to which isoform or possion distribution. this variance do not have any biological meaning. The true variance should include both the model variance and the biological replicate variance.

        In cuffdiff, which compare expression difference from two samples/conditions. I believe it estimate the variance from two different samples/conditions. but in this case, the hypothesis that most genes have similar expression level is not necessarily hold. So I think that is the reason why the variance is larger in cuffdiff result.

        What's your opinion?

        Comment

        Latest Articles

        Collapse

        • seqadmin
          Addressing Off-Target Effects in CRISPR Technologies
          by seqadmin






          The first FDA-approved CRISPR-based therapy marked the transition of therapeutic gene editing from a dream to reality1. CRISPR technologies have streamlined gene editing, and CRISPR screens have become an important approach for identifying genes involved in disease processes2. This technique introduces targeted mutations across numerous genes, enabling large-scale identification of gene functions, interactions, and pathways3. Identifying the full range...
          08-27-2024, 04:44 AM
        • seqadmin
          Selecting and Optimizing mRNA Library Preparations
          by seqadmin



          Sequencing mRNA provides a snapshot of cellular activity, allowing researchers to study the dynamics of cellular processes, compare gene expression across different tissue types, and gain insights into the mechanisms of complex diseases. “mRNA’s central role in the dogma of molecular biology makes it a logical and relevant focus for transcriptomic studies,” stated Sebastian Aguilar Pierlé, Ph.D., Application Development Lead at Inorevia. “One of the major hurdles for...
          08-07-2024, 12:11 PM

        ad_right_rmr

        Collapse

        News

        Collapse

        Topics Statistics Last Post
        Started by seqadmin, 08-27-2024, 04:40 AM
        0 responses
        16 views
        0 likes
        Last Post seqadmin  
        Started by seqadmin, 08-22-2024, 05:00 AM
        0 responses
        293 views
        0 likes
        Last Post seqadmin  
        Started by seqadmin, 08-21-2024, 10:49 AM
        0 responses
        135 views
        0 likes
        Last Post seqadmin  
        Started by seqadmin, 08-19-2024, 05:12 AM
        0 responses
        124 views
        0 likes
        Last Post seqadmin  
        Working...
        X